MedTrace Logo

Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program

NCT03556774 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2200

Last updated 2020-08-12

No results posted yet for this study

Summary

In this single-blind, randomized trial, undertaken in China with 8-week interventions and follow-up to 52 weeks, about 2,200 providers will be randomly allocated to the intervention or control group.

Conditions

  • Smoking Cessation Intervention
  • Smoking Abstinence

Interventions

BEHAVIORAL

'WeChat WeQuit' smoking cessation training program

Providing 'WeChat WeQuit' smoking cessation training program for healthcare service providers (HSPs) and assessing their utilization of behavioral and pharmacotherapy interventions for cigarette smoking cessation.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Sir Run Run Shaw Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556774 on ClinicalTrials.gov